lobbying_filings_raw: 7d35e459-e487-4eea-9359-933cfb2c45a6
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | amount_reported | is_amendment | is_no_activity | is_termination | raw_json |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7d35e459-e487-4eea-9359-933cfb2c45a6 | Q3 | 401055978 | MR. GALEN RESER | 197515 | PERRIGO INC (THROUGH FTI GOVERNMENT AFFAIRS) | 2014 | third_quarter | 2014-10-14T18:16:48.977000-04:00 | 10000.0 | 0 | 0 | 0 | {"url": "https://lda.senate.gov/api/v1/filings/7d35e459-e487-4eea-9359-933cfb2c45a6/", "filing_uuid": "7d35e459-e487-4eea-9359-933cfb2c45a6", "filing_type": "Q3", "filing_type_display": "3rd Quarter - Report", "filing_year": 2014, "filing_period": "third_quarter", "filing_period_display": "3rd Quarter (July 1 - Sep 30)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/7d35e459-e487-4eea-9359-933cfb2c45a6/print/", "filing_document_content_type": "text/html", "income": "10000.00", "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": "Galen Reser", "dt_posted": "2014-10-14T18:16:48.977000-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "325 7th Street, Northwest", "registrant_address_2": "Suite 400", "registrant_different_address": false, "registrant_city": "Washington", "registrant_state": "DC", "registrant_zip": "20004", "registrant": {"id": 401055978, "url": "https://lda.senate.gov/api/v1/registrants/401055978/", "house_registrant_id": null, "name": "MR. GALEN RESER", "description": "Government Relations Consulting", "address_1": "325 7th Street, Northwest", "address_2": "Suite 400", "address_3": null, "address_4": null, "city": "Washington", "state": "DC", "state_display": "District of Columbia", "zip": "20004", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "GALEN RESER", "contact_telephone": "+1 202-567-2929", "dt_updated": "2022-04-06T16:08:16.439648-04:00"}, "client": {"id": 197515, "url": "https://lda.senate.gov/api/v1/clients/197515/", "client_id": 24, "name": "PERRIGO INC (THROUGH FTI GOVERNMENT AFFAIRS)", "general_description": "Develop, manufacture, and distribute packaging of OTC & prescription pharmaceuticals.", "client_government_entity": false, "client_self_select": false, "state": "MI", "state_display": "Michigan", "country": "US", "country_display": "United States of America", "ppb_state": null, "ppb_state_display": null, "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2013-03-15"}, "lobbying_activities": [{"general_issue_code": "PHA", "general_issue_code_display": "Pharmacy", "description": "Repeals a requirement enacted into law as part of the PPACA of 2010 that requires consumers to obtain a prescription in order to utilize their FSA's and HSA's to purchase over-the-counter OTC medicines, H.R. 2835, \"Restoring Access to Medication Act of 2013.\" FDA's proposed changes to generic drug labeling. FDA's proposed Infant Formula regulations. House Energy and Commerce 21st Century Cures Initiative.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 58267, "prefix": "mr", "prefix_display": "MR.", "first_name": "GALEN", "nickname": null, "middle_name": "J.", "last_name": "RESER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "TAX", "general_issue_code_display": "Taxation/Internal Revenue Code", "description": "Monitor tax reform. Monitor developments to the Camp Tax Proposal.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 58267, "prefix": "mr", "prefix_display": "MR.", "first_name": "GALEN", "nickname": null, "middle_name": "J.", "last_name": "RESER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "Dextromethorphan. Pseudoephedrine restriction issues.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 58267, "prefix": "mr", "prefix_display": "MR.", "first_name": "GALEN", "nickname": null, "middle_name": "J.", "last_name": "RESER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} |